Русский
Possibilities of using meldonium in the treatment of subacute and chronic forms of cerebrovascular accident
DOI: https://dx.doi.org/10.18565/pharmateca.2024.4.164-169
Prokopenko S.V., Koryagina T.D.
Krasnoyarsk State Medical University n.a. Professor V.F. Voino-Yasenetsky, Krasnoyarsk, Russia
The article discusses the issue of cytoprotective therapy for chronic and subacute cerebral circulatory failure, the potential role of Meldonium in the correction of cognitive, emotional, and motor disorders in patients with cerebrovascular diseases, and provides an overview of modern clinical studies of the effectiveness of Meldonium in chronic subacute cerebral ischemia.
Keywords: cytoprotective therapy, meldonium, chronic cerebral ischemia, cerebrovascular disease, ischemic stroke
About the Autors
Corresponding author: Semyon V. Prokopenko, Dr. Sci. (Med.), Prof., Head of the Department of Nervous Diseases with a Course of Postgraduate Education, Professor at the Department of Physical and Rehabilitation Medicine with a Course of Postgraduate Education, Krasnoyarsk State Medical University
n.a. Professor V.F. Voino-Yasenetsky, Krasnoyarsk, Russias.v.proc.58@mail.ru
Similar Articles
